Future Live expands the enflog® line with the launch of enflog®Prost, a new food supplement based on Graminex® G63®, enflog®, zinc and selenium, developed to support prostate well-being, in cases of bacterial and non-bacterial prostatitis.
The product makes use of Graminex® G63®, a rye flower pollen extract, extensively documented in literature for its use in the context of prostate health, associated with enflog®, the enzymatic complex patented by the company consisting of the proteolytic enzymes Bromelain, Papain and Protease from Aspergillus oryzae fungus, selected for their ability to act in synergy on protein substrates of biological interest and for their interaction with bacterial biofilm. The formulation is completed by zinc and selenium, minerals that contribute to the protection of cells from oxidative stress.
The inclusion of enflog® in the formulation of enflog®Prost represents a distinctive element compared to commonly available solutions, enhancing the company’s patent heritage in an application of specific clinical interest.
Future Live is currently engaged in presenting enflog®Prost to medical specialists throughout the national territory.